申请人:Pinkerton Anthony B.
公开号:US20090035306A1
公开(公告)日:2009-02-05
The present invention relates to quinazolinone compounds useful as modulators of TGR5 and methods for the treatment or prevention of metabolic, cardiovascular, and inflammatory diseases.
本发明涉及喹唑酮类化合物,可用作TGR5调节剂,并用于治疗或预防代谢性、心血管和炎症性疾病的方法。